In 2018, Khurshid et al. [75] aimed to assess the predictive ability of tumor textural heterogeneity parameters in a total of 328 metastatic lesions from baseline [68Ga]Ga-PSMA-11 PET/CT of 70 mCRPC patients scheduled to undergo [177Lu]PSMA therapy. Here, FOLH1 is linked to neoplasm.